Litcius/Paper detail

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial

Felix Keil, Maximilian Hartl, Gabriela Altorjai, Andrea Berghold, Regina Riedl, Martin Pecherstorfer, Beate Mayrbäurl, Alexander de Vries, J. C. Schuster, Jutta Hackl, Thorsten Füreder, Thomas Melchardt, Martin Burian, Richard Greil

2021European Journal of Cancer21 citationsDOI

Topics & Concepts

DocetaxelCetuximabCisplatinMedicineOncologyChemotherapyInduction chemotherapyInternal medicineHead and neckHead and neck squamous-cell carcinomaBasal cellHead and neck cancerRadiation therapyCancerSurgeryColorectal cancerHead and Neck Cancer StudiesNonmelanoma Skin Cancer StudiesHead and Neck Surgical Oncology
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial | Litcius